Specgx LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWebster Groves, MO
US patents21
SAM.gov UEISJ9MSB1UXGL8
CAGE code84GK4
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
21 US patents granted 2018–2025, 15 of them in the five years to SEP 2025.
Pharmaceuticals 16Organic fine chemistry 4IT methods for management 1
- Preparation of sufentanil citrate and sufentanil baseUS 12,371,423 · granted JUL 29, 2025
- Extended release, abuse deterrent dosage formsUS 12,208,094 · granted JAN 28, 2025
- Systems and methods for high humidity curing within tablet coating systemUS 11,666,509 · granted JUN 6, 2023
- Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesUS 11,617,712 · granted APR 4, 2023
- Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesUS 11,583,493 · granted FEB 21, 2023
Newest 5 shown · Granted to SpecGX LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Specgx LLC | Webster Groves | MO | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.